|View printer-friendly version|
|July 01, 2002 4:16 p.m.|
|Teva Announces Approval of Lisinopril Tablets and Lisinopril HCTZ Tablets|
Jerusalem, Israel, July 1, 2002 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U. S. Food and Drug Administration has issued final approval for the company's ANDA for Lisinopril Tablets USP, 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg and 40 mg as well as its ANDA for Lisinopril and Hydrochlorothiazide Tablets, 10 mg/12.5 mg, 20 mg/12.5 mg and 20 mg/25 mg. Both products will be shipped immediately.